Specifically HER2 overexpression is associated with development of histological alterations of early-stage BC tissues36, 37, and the overexpression in DCIS (early-stage cancer) lesions predicts invasive disease progression14. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.